Cambridge Healthtech Institute’s 13th Annual

Kinase Inhibitor Discovery

Emerging Targets, New Tools and Strategies, and Targeted Kinase Degraders

September 17-18, 2020

 

Kinase inhibitor discovery is a very active area as developers are exploring more deeply into designing immune-modulatory agents as single or combination therapies, tackling chronic disease indications such as inflammation and CNS disorders, as well as effectively harnessing allosteric modulators, and covalently binding compounds. This year we will also be discussing the role of artificial intelligence, new and non-oncology drug targets, phosphatases, and protein degraders in kinase development. Cambridge Healthtech Institute’s 13th Annual Kinase Inhibitor Discovery conference will once again bring together academic and industry leaders to network, collaborate, and discuss advances in kinase inhibitor discovery and development.

 

Who should attend: Presidents, Vice Presidents, CEOs, CTOs, Medicinal Chemists and Scientists working in Drug Discovery and Development from Academia, Government, or Industry.

 

Coverage will include, but is not limited to:                                        

  • Targeted Kinase Degradation Strategies
  • Artificial Intelligence in Kinase Drug Design and Discovery
  • Tryosine Kinase Inhibitors
  • Covalent Kinase Inhibitors
  • Target Covalent Inhibitors
  • Macrocycle Inhibitors
  • Reversible Inhibitors
  • Fragment and Structure-Based Design
  • Lead & Target Optimization
  • Phosphatases

 

If you would like to submit a proposal to give a presentation at this meeting, please click here.

 

The deadline for priority consideration is February 26, 2020.

 

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

 

For more details on the conference, please contact:
Nandini Kashyap, MS

Conference Director

Cambridge Healthtech Institute

Phone: (+1) 781-972-5406
Email: nkashyap@healthtech.com

 

For partnering and sponsorship information, please contact:
Rod Eymael

Manager, Business Development

Cambridge Healthtech Institute

Phone: (+1) 781-247-6286
Email: reymael@healthtech.com